-BioLife Solutions, Inc. (NASDAQ:BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that its common stock will be added to the S&P SmallCap 600 Index effective prior to the opening of trading on Monday, August 30, 2021.
Mike Rice, BioLife Solutions Chairman and CEO, commented, “This is a great honor and recognition of the hard work the BioLife team has put in over many years to create long term shareholder value. Our quality culture empowers our team members to relentlessly focus on our customers, who have rewarded BioLife and our shareholders.”
